Filter Results:
(5,441)
Show Results For
- All HBS Web
(5,441)
- People (18)
- News (2,029)
- Research (2,727)
- Events (7)
- Multimedia (222)
- Faculty Publications (1,997)
Show Results For
- All HBS Web
(5,441)
- People (18)
- News (2,029)
- Research (2,727)
- Events (7)
- Multimedia (222)
- Faculty Publications (1,997)
- Web
Student Spotlight: From Nigeria to HBS: Reigniting My Passion for Healthcare Innovation - Blog: Health Supplement
Blog Blog Health Care and Life Science at HBS Filter Results Arrow Down Arrow Up Read posts from Author Alumni Author Blavatnik Fellow Author Blavatnik Fellowship Team Author Executive Education Author HBS... View Details
- 04 Apr 2014
- News
What It Really Takes to Listen to Patients
- March 2020
- Case
China's Management of COVID-19 (A): People's War or Chernobyl Moment?
By: Meg Rithmire and Courtney Han
In late 2019, a novel respiratory virus appeared in a province in central China. Government officials in Wuhan, Hubei province had to respond to the new virus in the shadow of the 2002–2003 outbreak of SARS in China and within the context of the country’s public health... View Details
Keywords: COVID-19; Coronavirus; Pandemics; Public Health; COVID-19 Pandemic; Health Pandemics; Government Administration; Social Issues; Policy; Decision Making; China
Rithmire, Meg, and Courtney Han. "China's Management of COVID-19 (A): People's War or Chernobyl Moment?" Harvard Business School Case 720-035, March 2020.
- July 1990
- Case
Food Science Corp. (FSC)--Cholesterol Extraction and Other Technology Applied to Health Hazards in the Food Chain
By: Ray A. Goldberg
Goldberg, Ray A. "Food Science Corp. (FSC)--Cholesterol Extraction and Other Technology Applied to Health Hazards in the Food Chain." Harvard Business School Case 591-018, July 1990.
- October 2002
- Book Review
Book Review of Beatrix Hoffman's The Wages of Sickness: The Politics of Health Insurance in Progressive America
By: David A. Moss
Moss, David A. "Book Review of Beatrix Hoffman's The Wages of Sickness: The Politics of Health Insurance in Progressive America." Journal of Health Politics, Policy and Law 27, no. 5 (October 2002): 869–873.
- Editorial
Zeroing Out on zero-COVID
By: William C. Kirby
China’s culture reveres science, yet operates under a government that often defines what “science” is and is not. China’s “zero-COVID” policy has created a bifurcated scientific community that threatens international collaboration in science and technology. A... View Details
Keywords: COVID; Scientific Community; World Health Organization; Pseudoscience; Governance; Government and Politics; Health; Research and Development; Social Media; China
Kirby, William C. "Zeroing Out on zero-COVID." Science 376, no. 6597 (June 2, 2022): 1026.
- March 5, 2022
- Article
Hospital Capacity Shortages: An SEC-Backed Transparency “PULL” Will Open Beds Faster Than a “PUSH” by HHS
In the new normal of ongoing pandemics, hospital bed shortages will continue. Healthcare innovation expert and author of the upcoming book Innovating in Healthcare: Creating Breakthrough Services, Products, and Business Models (Wiley, 2023, 978-1119543008), HBS... View Details
Keywords: Hospital Capacity; Access To Care; Health Pandemics; Health Care and Treatment; Performance Capacity; Planning
Herzlinger, Regina E. "Hospital Capacity Shortages: An SEC-Backed Transparency “PULL” Will Open Beds Faster Than a “PUSH” by HHS." Healthcare Business Today (March 5, 2022).
Bohan Li
Bohan is a doctoral student in Health Policy Management. She graduated from the University of Pennsylvania in 2018 with a double major in Chemistry and Economics. Post-graduation, Bohan spent 4 years as a management consultant advising both payers and providers,... View Details
- November 2013 (Revised January 2015)
- Case
Obamacare
By: Matthew Weinzierl and Katrina Flanagan
One vote in June, 2012, decided the fate of President Barack Obama's crowning first-term achievement: universal health insurance. Chief Justice John Roberts of the U.S. Supreme Court cast the deciding vote to uphold the keystone of the reform: the mandate to purchase... View Details
Keywords: Universal Health Insurance; Adverse Selection; Leviathan; Courts and Trials; Judgments; Insurance; Health Care and Treatment; Government and Politics; Health Industry; Health Industry; Health Industry; United States
Weinzierl, Matthew, and Katrina Flanagan. "Obamacare." Harvard Business School Case 714-029, November 2013. (Revised January 2015.)
- Article
TDABC Cost Analysis of Ocular Disorders in an Ophthalmology Emergency Department versus Urgent Care: Clinical Experience at Massachusetts Eye and Ear
By: Robert S. Kaplan, Jonathan Chou, Mahek Shah, Amy Watts, Matthew Gardiner, Joan Miller and John I. Lowenstein
Purpose
To perform a cost analysis comparison for managing common ocular disorders in an eye emergency department (ED) versus an urgent care setting using a time-driven activity-based cost model (TDABC) to assist physicians and staff in appropriate allocation of... View Details
Keywords: Time-driven Activity-based Cost Model; Emergency Room; Urgent Care Clinic; Cost; Analysis; Activity Based Costing and Management; Health Care and Treatment
Kaplan, Robert S., Jonathan Chou, Mahek Shah, Amy Watts, Matthew Gardiner, Joan Miller, and John I. Lowenstein. "TDABC Cost Analysis of Ocular Disorders in an Ophthalmology Emergency Department versus Urgent Care: Clinical Experience at Massachusetts Eye and Ear." Journal of Academic Ophthalmology 10 (2018).
- October 2014 (Revised April 2023)
- Case
Gilead: Hepatitis C Access Strategy (A)
By: V. Kasturi Rangan, Vikram Rangan and David E. Bloom
Gilead had come up with an innovative drug for Hepatitis C, which affected 180 million people worldwide. The drug was priced at $1,000 a pill for the US market. Gilead had to decide how to price and market the pill in developing countries that bore the brunt of the... View Details
Keywords: Healthcare; Pharmaceuticals; Pricing; Access To Care; Emerging Markets; Health Care and Treatment; Price; Strategy; Ethics; Health Industry; Health Industry
Rangan, V. Kasturi, Vikram Rangan, and David E. Bloom. "Gilead: Hepatitis C Access Strategy (A)." Harvard Business School Case 515-025, October 2014. (Revised April 2023.)
Regina E. Herzlinger
Regina E. Herzlinger is the Nancy R. McPherson Professor of Business Administration at the Harvard Business School. She was the first woman to be tenured and chaired at Harvard Business School and serve on many established and start-up corporate health care/medical... View Details
- 2020
- Working Paper
Fresh Fruit and Vegetable Consumption: The Impact of Access and Value
By: Retsef Levi, Elisabeth Paulson and Georgia Perakis
The goal of this paper is to leverage household-level data to improve food-related policies aimed at increasing the consumption of fruits and vegetables (FVs) among low-income households. Currently, several interventions target areas where residents have limited... View Details
Keywords: Food Deserts; Food Access; Food Policy; Causal Inference; Food; Nutrition; Poverty; Government Administration
Levi, Retsef, Elisabeth Paulson, and Georgia Perakis. "Fresh Fruit and Vegetable Consumption: The Impact of Access and Value." MIT Sloan Research Paper, No. 5389-18, October 2020.
- 15 Apr 2012
- News
Why Medical Bills Are a Mystery
- March 2014 (Revised September 2014)
- Supplement
Cancer Treatment Centers of America® (B)
By: Regina E. Herzlinger and Natalie Kindred
This case, a follow-up to Cancer Treatment Centers of America (A), HBS No. 313-012, begins with the debate over New Hampshire's certificate-of-need (CON) law, which restricts hospital expansion. This debate ignited significant public criticism of Cancer Treatment... View Details
Keywords: Cancer; Cancer Treatment; Accountability; Outcomes; Outcomes Reporting; Outcomes Measurement; Survival; For-profit Hospitals; Health Care; Healthcare; Hospital; Certificate Of Need; Health Care and Treatment; Outcome or Result; Corporate Accountability; Policy; Health Industry; United States
Herzlinger, Regina E., and Natalie Kindred. "Cancer Treatment Centers of America® (B)." Harvard Business School Supplement 314-003, March 2014. (Revised September 2014.)
- Article
Decreases In Readmissions Credited to Medicare's Program to Reduce Hospital Readmissions Have Been Overstated
By: Christopher Ody, Lucy Msall, Leemore S. Dafny, David Grabowski and David Cutler
Medicare’s Hospital Readmissions Reduction Program (HRRP) has been credited with lowering risk-adjusted readmission rates for targeted conditions at general acute care hospitals. However, these reductions appear to be illusory or overstated. This is because a... View Details
Keywords: Readmission Rates; Hospitals; Acute Care Hospitals; Medicare; Myocardial Infarction; Heart Failure; Health Care and Treatment
Ody, Christopher, Lucy Msall, Leemore S. Dafny, David Grabowski, and David Cutler. "Decreases In Readmissions Credited to Medicare's Program to Reduce Hospital Readmissions Have Been Overstated." Health Affairs 38, no. 1 (January 2019): 36–43.
Leemore S. Dafny
Leemore Dafny is the Bruce V. Rauner Professor of Business Administration and the Howard Cox Health Care Initiative Faculty Co-Chair at the Harvard Business School. She also serves as Professor of Public Policy at the Harvard Kennedy School. Dafny is an... View Details
Keywords: health care